发明授权
- 专利标题： SULFONAMIDE DERIVATIVES AS PPAR MODULATORS
- 专利标题（中）： 磺酰胺衍生物AS PPAR调节因子
-
申请号： EP04709806.6申请日： 2004-02-10
-
公开(公告)号： EP1597248B1公开(公告)日： 2007-12-26
- 发明人: CONNER, Scott, Eugene , GOSSETT, Lynn, Stacy , GREEN, Jonathan, Edward , JONES, Winton, Dennis Jr. , MANTLO, Nathan, Bryan , MATTHEWS, Donald, Paul , MAYHUGH, Daniel, Ray , SMITH, Daryl, Lynn , VANCE, Jennifer, Ann , WANG, Xiaodong , WARSHAWSKY, Alan, M , WINNEROSKI, Leonard, Larry Jr. , XU, Yanping , ZHU, Guoxin
- 申请人： ELI LILLY AND COMPANY
- 申请人地址： Lilly Corporate Center Indianapolis, Indiana 46285 US
- 专利权人： ELI LILLY AND COMPANY
- 当前专利权人： ELI LILLY AND COMPANY
- 当前专利权人地址： Lilly Corporate Center Indianapolis, Indiana 46285 US
- 代理机构： Burnside, Ivan John
- 优先权： US448307P 20030214
- 国际公布： WO2004073606 20040902
- 主分类号： C07D333/62
- IPC分类号： C07D333/62 ; C07D409/12 ; C07C311/29 ; C07C311/16 ; C07D213/71 ; C07D231/18 ; C07D213/74 ; C07D263/32 ; C07D333/34 ; C07D231/12 ; C07D277/36 ; C07D319/18 ; C07D409/04 ; C07D307/79
摘要：
The present invention is directed to a compound of Formula (I):, and pharmaceutically acceptable salts, solvates, hydrates or stereoisomers thereof, which are useful in treating or preventing disorders mediated by a peroxisome proliferator activated receptor (PPAR) such as syndrome X, type II diabetes, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, arteriosclerosis, and other disorders related to syndrome X and cardiovascular diseases.
公开/授权文献
- EP1597248A2 SULFONAMIDE DERIVATIVES AS PPAR MODULATORS 公开/授权日：2005-11-23
信息查询
